[Medical and legal issues related to the drugs currently used in the treatment of Age-Related Macular Degeneration (ARMD)].
Menéndez de Lucas
J A
JA
Morcillo Laiz
R
R
D052157:Aptamers, Nucleotide / Q000627:therapeutic use; D004363:Drug Utilization / Q000331:legislation & jurisprudence; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D017319:Photosensitizing Agents / Q000627:therapeutic use; D011166:Porphyrins / Q000627:therapeutic use; D013030:Spain; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D000077362:Verteporfin
D052157:Aptamers, Nucleotide; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; C495058:pegaptanib; D014222:Triamcinolone Acetonide